- A t(8;9)(p22;p24)/PCM1-JAK2 Translocation in a Patient With Myeloproliferative Neoplasm and Myeloid Sarcoma: First Report in Korea
-
Song I, Lee DH, Lee JH, Jang S, Huh JR, Seo EJ
- KMID: 2373505
- Ann Lab Med.
- 2016 Jan;36(1):79-81.
- doi: 10.3343/alm.2016.36.1.79
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Myeloproliferative Neoplasm with a Concurrent JAK2V617F Mutation and BCR/ABL Translocation without Chronic Myelogenous Leukemia Phenotype Acquisition during Hydroxyurea Treatment
-
Park SH, Chi HS, Cho YU, Jang S, Park CJ, Kim DY, Lee JH, Lee KH
- KMID: 1781334
- Ann Lab Med.
- 2013 May;33(3):229-232.
- doi: 10.3343/alm.2013.33.3.229
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Correlations between Janus Kinase 2 V617F Allele Burdens and Clinicohematologic Parameters in Myeloproliferative Neoplasms
-
Ha JS, Kim YK, Jung SI, Jung HR, Chung IS
- KMID: 2434478
- Ann Lab Med.
- 2012 Nov;32(6):385-391.
BACKGROUND: This study evaluated potential correlations between the allele burden of the Janus kinase 2 (JAK2) V617F mutation and clinicohematologic characteristics in patients with myeloproliferative neoplasms (MPN). METHODS: Clinical and hematologic... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
-
Kubuki Y, Shide K, Kameda T, Yamaji T, Sekine M, Kamiunten , Akizuki K, Shimoda H, Tahira Y, Nakamura K, Abe H, Miike T, Iwakiri H, Tahara Y, Sueta M, Hashimoto , Yamamoto S, Hasuike S, Hidaka T, Nagata K, Kitanaka A, Shimoda K
- KMID: 2373635
- Ann Lab Med.
- 2017 Mar;37(2):159-161.
- doi: 10.3343/alm.2017.37.2.159
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic Usefulness of the Janus Kinase 2 Mutation in non BCR/ABL Myeloproliferative Disorders
-
Bang SM, Ahn JY, Park J, Yoo SJ, Park SH, Nam EM, Park PW, Seo YH, Cho EK, Shin DB, Lee JH
- KMID: 759854
- Korean J Intern Med.
- 2006 Dec;21(4):219-224.
- doi: 10.3904/kjim.2006.21.4.219
BACKGROUND: We investigated the Janus kinase 2 (JAK2) mutation and its diagnostic value in patients suffering with non BCR/ABL myeloproliferative diseases (nMPD) or other reactive conditions. METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- JAK2(V617F) Mutation in Korean Patients with Essential Thrombocythemia
-
Ahn JY, Yoo SJ, Bang SM, Park PW, Seo YH, Shin DB, Lee JH
- KMID: 1781463
- Korean J Lab Med.
- 2007 Apr;27(2):77-82.
- doi: 10.3343/kjlm.2007.27.2.77
BACKGROUND: Essential thrombocythemia (ET) is thought to reflect transformation of a multipotent hematopoietic stem cell, but its molecular pathogenesis remains obscure. But tyrosine kinase, especially Janus kinase 2 (JAK2),... -
- CITED
-
- Close
- SHARE
-
- Close
- JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis
-
Kim BH, Cho YU, Bae MH, Jang S, Seo EJ, Chi HS, Choi Y, Kim DY, Lee JH, Lee JH, Lee KH, Park YM, Lee JK, Park CJ
- KMID: 2164472
- J Korean Med Sci.
- 2015 Jul;30(7):882-888.
- doi: 10.3346/jkms.2015.30.7.882
Mutations in the calreticulin gene, CALR, have recently been discovered in subsets of patients with essential thrombocythemia (ET) or primary myelofibrosis (PMF). We investigated Korean patients with ET and PMF... -
- CITED
-
- Close
- SHARE
-
- Close
- JAK2 V617F and MPL W515L/K Mutations in Korean Patients with Essential Thrombocythemia
-
Kim HJ, Jang JH, Yoo EH, Kim HJ, Ki CS, Kim JW, Kim SH
- KMID: 1022037
- Korean J Lab Med.
- 2010 Oct;30(5):474-476.
- doi: 10.3343/kjlm.2010.30.5.474
JAK2 V617F and MPL W515L/K mutations have been reported in approximately 50% and 5% of the patients with essential thrombocythemia (ET), respectively. We investigated the frequency of MPL W515L/K mutations... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Real-time Semi-quantitative PCR, JAK2 MutaScreen (TM) Kit for JAK2 V617F Screening
-
Chae H, Lee JH, Lim J, Jung SW, Kim M, Kim Y, Han K, Cho BS, Cho SG, Lee JW, Min WS
- KMID: 1096977
- Korean J Lab Med.
- 2009 Jun;29(3):243-248.
- doi: 10.3343/kjlm.2009.29.3.243
BACKGROUND: Real-time PCR for quantification of JAK2 V617F has recently been introduced and used to evaluate the importance of mutant allele burden in both diagnosis and disease progression in myeloproliferative... -
- CITED
-
- Close
- SHARE
-
- Close
- JAK2 V617F and Exon 12 Genetic Variations in Korean Patients with BCR/ABL1-negative Myeloproliferative Neoplasms
-
Kim JT, Cho YG, Choi SI, Lee YJ, Kim HR, Jang SJ, Moon DS, Park YJ, Park G
- KMID: 1781660
- Korean J Lab Med.
- 2010 Dec;30(6):567-574.
- doi: 10.3343/kjlm.2010.30.6.567
BACKGROUND: JAK2 genetic variations have been described in a high proportion of patients with BCR/ABL1-negative myeloproliferative neoplasms (MPN). This study was designed to analyze the frequencies of JAK2 V617F and... -
- CITED
-
- Close
- SHARE
-
- Close
